Prevalence of anticipatory nausea and emesis in cancer chemotherapy patients
- 1 December 1982
- journal article
- research article
- Published by Springer Nature in Journal of Behavioral Medicine
- Vol. 5 (4), 461-463
- https://doi.org/10.1007/bf00845373
Abstract
The prevalence of anticipatory nausea (AN) and anticipatory emesis (AE) in 71 cancer chemotherapy outpatients was measured by a self-report questionnaire. An 18.3% prevalence rate was found, with a mean onset of 5.12 hr prior to treatment. AN/AE most typically occurred at home or while traveling to the clinic and those who experienced it also reported a significantly higher frequency of posttreatment nausea, vomiting, constipation, and dry and itching skin.This publication has 9 references indexed in Scilit:
- Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy.Journal of Consulting and Clinical Psychology, 1982
- Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy.Journal of Consulting and Clinical Psychology, 1982
- The Control of Chemotherapy-Induced EmesisAnnals of Internal Medicine, 1981
- Pretreatment Nausea in Cancer Chemotherapy: A Conditioned Response?*Psychosomatic Medicine, 1980
- Chemotherapy-induced nausea and vomiting.1979
- Chemotherapy-Induced Nausea and VomitingThe American Journal of Nursing, 1979
- Cancer chemotherapy--a nursing model.1978
- Cancer Chemotherapy — A Nursing ModelNursing Clinics of North America, 1978